DE2204069C3 - 2,2-Dimethyl-7α, 13βdialkylgonatriene, Verfahren zu deren Herstellung, diese enthaltende Arzneimittelsowie Zwischenprodukte
- Google Patents
2,2-Dimethyl-7α, 13βdialkylgonatriene, Verfahren zu deren Herstellung, diese enthaltende Arzneimittelsowie Zwischenprodukte
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SAfiledCriticalRoussel Uclaf SA
Publication of DE2204069A1publicationCriticalpatent/DE2204069A1/de
Publication of DE2204069B2publicationCriticalpatent/DE2204069B2/de
Application grantedgrantedCritical
Publication of DE2204069C3publicationCriticalpatent/DE2204069C3/de
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
DE197222040691971-01-281972-01-282,2-Dimethyl-7α, 13βdialkylgonatriene, Verfahren zu deren Herstellung, diese enthaltende Arzneimittelsowie Zwischenprodukte
ExpiredDE2204069C3
(de)
3-OXO-7 a , 17 a -dimethyl- 13 ß -äthyl-17 ß -hydroxy-gona-4,9,11-trien, Verfahren zu seiner Herstellung, dabei auftretende Zwischenprodukte sowie Arzneimittel
18,19-dinor-13beta-alkylpregna-4,9,11triene, verfahren zur herstellung dieser verbindungen sowie diese verbindungen enthaltende pharmazeutische zusammensetzungen